Application no. and date | 99906749.9 (espacenet) (Federated) (European Patent Register), 19990209 | Patent/reg. no. and date | DK/EP 1053012, 20030723 | Publication date | 20001122 | Priority no. and date | US 74066 P, 19980209 | EP pub. no. and date |
EP 1053012 20001122 | Effective date | | Applicant/owner | Enzon Pharmaceuticals, Inc., 685 Route 202/206
Bridgewater, New Jersey 08807, US | Applicant ref. no. | 108087 | Inventor | AVRAMIS, Vassilios, I., 13434 Aldergrove
Sylmar, CA 91342, US, COHEN, Lewis, 100 Beechwood Terrace
Pottstown, PA 19464, US | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 38/50 (2006.01) , A61P 31/18 (2006.01) | Title | Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner | Int. application no. | US1999002480 | Int. publication no. | WO1999039732 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|